Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer

Stephanie L. Hines, Betty Anne Mincey, Jeff A. Sloan, Sachdev P. Thomas, Elaine Chottiner, Charles L. Loprinzi, Mark D. Carlson, Pamela J. Atherton, Muhammad Salim, Edith A. Perez

Research output: Contribution to journal › Article › peer-review

72 Scopus citations

Fingerprint

Dive into the research topics of 'Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences